Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Details:

Title

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Collection

NT trends in ecstasy and related drug markets; Reports; PublicationNT

Date

2011

Description

Made available via the Publications (Legal Deposit) Act 2004 (NT).

Notes

Date:2011; Australian drug trends series No. 80

Language

English

Subject

Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)

ISBN

9780733430206

Copyright owner

Check within Publication or with content Publisher.

Parent handle

https://hdl.handle.net/10070/242182

Citation address

https://hdl.handle.net/10070/610318

Page content

21 4.6 Other opioids Key Points Morphine remained the opioid most frequently used by participants, with 81% having used some form of morphine in the preceding six months, on a median of 180 days. MS Contin continued to be the brand most often used. Illicitly obtained methadone was used by 11% of participants in the preceding six months, on a median of five days. Illicitly obtained Physeptone tablets were used by 27% of participants in the preceding six months, on a median of five days. Illicitly obtained oxycodone was used by 26% of participants in the preceding six months, on a median of three days. Illicitly obtained Subutex was used by 8% of participants in the preceding six months, on a median of six days. Illicitly obtained Suboxone was used by 14% of participants in the preceding six months, on a median of 2 days. Over-the-counter (OTC) codeine was used by 52% of participants in the preceding six months, on a median of 18 days. Other opioids were used by 41% of participants in the preceding six months, on a median of 12 days. 4.6.1 Methadone In 2011, 11% of the sample reported use of illicit methadone liquid in the preceding six months, the same proportion as in 2010 (Table 11). Those who recently used illicit methadone did so on a median of 5 days, as compared to 2 days in 2010 (Table 3). The recent use of illicit methadone exceeded that of licit methadone, as did the recent use of illicit Physeptone (27% compared to 5% who reported use of licit Physeptone). Table 11: Forms of methadone used previous six months and primary form, 2007-2011 (%) 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011 N=98 Used Most often Used Most often Used Most often Used Most often Used Most often Methadone Licit 17 4 9 7 6 3 6 5 3 2 Illicit 17 4 25 16 15 10 11 1 11 5 Physeptone Licit 9 2 3 1 6 4 8 7 5 5 Illicit 26 12 36 26 22 9 26 17 27 20 Source: IDRS participant interviews For both illicit methadone syrup and Physeptone tablets, a pattern of weekly or less use was again the most common frequency reported (Table 12).